Sunday, October 18, 2026

USD/CHF Is 3% Up In The Last 21 Sessions

USD/CHF Is 3% Up In The Last 21 Sessions

(VIANEWS) - USD/CHF (USDCHF) has been up by 3.17% for the last 21 sessions. At 18:09 EST on Monday, 8 April, USD/CHF (USDCHF) is $0.91.

USD/CHF's yearly highs and lows, it's 8.655% up from its 52-week low and 2.077% down from its 52-week high.

Volatility

USD/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.10%, a positive 0.13%, and a positive 0.30%, respectively.

USD/CHF's highest amplitude of average volatility was 0.25% (last week), 0.29% (last month), and 0.30% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd rebounds to 1.0850 as market sentiment improves, US inflation in focus. According to FXStreet on Monday, 8 April, "The EUR/USD pair bounces back to 1.0850 in Monday's early American session as appeal for risky assets improve. "
  • Eur/usd analysis: bearish performance - 08 April 2024. According to DailyForex on Monday, 8 April, "The decline in the EUR/USD price accelerated, as the pair fell to its lowest level since February 15 of this year. ", "Therefore, the outlook for the EUR/USD pair is very bearish, with the next level to watch being the support at 1.0690, and a drop below this level will see the pair retreat to the main support level at 1.0600. "
  • Eur/usd trades with modest losses amid stronger usd, holds above 1.0800 mark. According to FXStreet on Monday, 8 April, "The outlook keeps the US Treasury bond yields elevated, which, in turn, is seen acting as a tailwind for the USD and exerting some pressure on the EUR/USD pair.", "This, along with the European Central Bank (ECB) meeting on Thursday, should provide some meaningful impetus to the EUR/USD pair."
  • Eur/usd price analysis: falls to near 1.0830 as bearish stance remains robust. According to FXStreet on Monday, 8 April, "Additionally, technical analysis suggests a bearish sentiment for the EUR/USD pair. ", "The EUR/USD pair could find immediate support at the psychological level of 1.0800. "
  • Eur/usd weekly forecast: choppy trading routine as outlooks remain unclear - 07 April 2024. According to DailyForex on Sunday, 7 April, "The EUR/USD traded in a choppy manner all of last week and although it finished slightly higher than where it started, speculators who are bulls will not be resting easy.", "Trading early this week should be watched carefully in order to gauge behavioral sentiment which remains fragile, but if the EUR/USD remains stable in the first handful of hours on Monday this could begin to prove Forex now believes the existing price range is balanced. "

More news about USD/CHF (USDCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,396 source documents archived
Query this data → isubstrate.com